Trial: 201802162

Los Tres Paso Trial: Step One Neoadjuvant Palbociclib Monotherapy, Step Two Concurrent Chemoradiation Therapy, and Step Three Adjuvant Palbociclib Monotherapy in Patients with p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

Phase

II

Principal Investigator

Adkins, Douglas

Disease Site

Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov